ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma

BACKGROUND: ARL9 is a newly identified member of the ARF family, and the clinical significance of ARL9 in colon adenocarcinoma is unknown. In this study, we aimed to explore the expression of ARL9 mRNA in colon adenocarcinoma, and its effect on the prognosis of patients with colon adenocarcinoma. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hai-deng, Jin, Xiu-xiu, Gu, Bin-bin, Yu-Zhang, Li, Dan, Yan, Ling-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951453/
https://www.ncbi.nlm.nih.gov/pubmed/36823542
http://dx.doi.org/10.1186/s12876-023-02677-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951453/
https://www.ncbi.nlm.nih.gov/pubmed/36823542
http://dx.doi.org/10.1186/s12876-023-02677-8

Ejemplares similares